✦ LIBER ✦

Primary endocrine therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients

✍ Scribed by V. Semiglazov; Kletsel; E. Zhiltsova; V. Ivanov; G. Dashyan; A. Bozhok; O. Melnikova; R. Paltuev; L. Berstein; V. Semiglazov

Book ID: 118624540
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 131 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)80260-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative hormonal therapy vs chemoth

Preoperative hormonal therapy vs chemotherapy in postmenopausal ER-positive breast cancer patients

✍ V.F Semiglazov; V.V Semiglazov; V.G Ivanov; E.K Ziltsova; G.A Dashian; A Kletzel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

P85 Direct comparison of primary (neoadj

P85 Direct comparison of primary (neoadjuvant) endocrine therapy vs primary chemotherapy in postmenopausal women with ER-positive breast cancer

✍ V. Semiglazov; V. Ivanov; A. Bozhok; A. Kletzel; E. Ziltzova; O. Melnikova; R. P 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

0177 Primary endocrine therapy versus ch

0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year results

✍ V.F. Semiglazov; G.A. Dashyan; V.V. Semiglazov; E.K. Ziltsova; A.A. Malodusheva; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/

P131 The neoadjuvant endocrinetherapy vs

P131 The neoadjuvant endocrinetherapy vs chemotherapy in postmenopausal woment with ER-positive breast cancer

✍ V.F. Semiglazov; V.V. Semiglazov; V.G. Ivanov; E.R. Zhiltzova; A.E. Kletsel; G.A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Pathologic Response and Locoregional Out

Pathologic Response and Locoregional Outcome in Post-menopausal ER Positive Breast Cancer Patients Receiving Neoadjuvant Endocrine Therapy vs. Cytotoxic Chemotherapy

✍ K. Saigal; A.M. Saeed; J. Hurley; C. Takita; I.M. Reis; W. Zhao; T. Ambros; V. E 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB